ENZN - Enzon Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 513.71M
Enterprise Value 38.77M
Trailing P/E
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1.49
Price/Book (mrq)1.58
Enterprise Value/Revenue 30.95
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017

Profitability

Profit Margin 4.00%
Operating Margin (ttm)87.34%

Management Effectiveness

Return on Assets (ttm)32.69%
Return on Equity (ttm)2.44%

Income Statement

Revenue (ttm)9.22M
Revenue Per Share (ttm)0.21
Quarterly Revenue Growth (yoy)-92.30%
Gross Profit (ttm)8.38M
EBITDA N/A
Net Income Avi to Common (ttm)369k
Diluted EPS (ttm)0.00
Quarterly Earnings Growth (yoy)-83.70%

Balance Sheet

Total Cash (mrq)4.32M
Total Cash Per Share (mrq)0.1
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)21.31
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)4.69M
Levered Free Cash Flow (ttm)1.89M

Trading Information

Stock Price History

Beta -0.10
52-Week Change 347.06%
S&P500 52-Week Change 318.23%
52 Week High 30.35
52 Week Low 30.03
50-Day Moving Average 30.31
200-Day Moving Average 30.24

Share Statistics

Avg Vol (3 month) 383.51k
Avg Vol (10 day) 359.07k
Shares Outstanding 544.21M
Float 35.11M
% Held by Insiders 15.67%
% Held by Institutions 115.02%
Shares Short 3157.47k
Short Ratio 31.03
Short % of Float 30.41%
Shares Short (prior month) 3298.38k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 40.00%
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Sep 28, 2017
Ex-Dividend Date 4Dec 30, 2015
Last Split Factor (new per old) 25/3
Last Split Date 3Sep 29, 2017